Denmark vs Republic of Moldova: Protecting minority investors: Ease of shareholder suits index (0-10)
Denmark
70
in 2013
Republic of Moldova
70
in 2013
Denmark rank
44th
Republic of Moldova rank
44th
Protecting minority investors: Ease of shareholder suits index (0-10) over time
- Denmark
- Republic of Moldova
How they compare
Denmark currently reports 70 against 70 in Republic of Moldova, a difference of 0.
Across all 9 years both countries report, Republic of Moldova has been ahead every year.
Denmark ranks 44th and Republic of Moldova ranks 44th of 191 countries.
Head to head by decade
| Decade | Denmark | Republic of Moldova | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 70 | 70 | 0 | — |
| 2010s | 70 | 70 | 0 | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher protecting minority investors: ease of shareholder suits index (0-10), Denmark or Republic of Moldova?
- Denmark, at 70 against 70 in Republic of Moldova as of 2013.
- What is the difference in protecting minority investors: ease of shareholder suits index (0-10) between Denmark and Republic of Moldova?
- 0, with Denmark ahead.
- How many years of comparable data are there for Denmark and Republic of Moldova?
- 9 years are reported by both, from 2005 to 2013.
- How do Denmark and Republic of Moldova rank globally for protecting minority investors: ease of shareholder suits index (0-10)?
- Denmark ranks 44th and Republic of Moldova ranks 44th of 191 countries.
- Where does this data come from?
- The World Bank, published as Protecting minority investors: Ease of shareholder suits index (0-10) (DB06-14 methodology) - Score. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The score for ease of shareholder suits index benchmarks economies with respect to the regulatory best practice on the indicator. The score is indicated on a scale from 0 to 100, where 0 represents the worst regulatory performance and 100 the best regulatory performance, and is computed based on the methodology in the DB06-14 studies.